Company profile: Synlab
1.1 - Company Overview
Company description
- Provider of laboratory diagnostics for human and veterinary medicine and environmental analysis services. Delivers wide-ranging laboratory testing, specialty and genetic testing (including preimplantation), supported by 2,000+ medical experts across 30+ countries and 2,000+ blood collection points. Also focuses on medical supplies trade, clinical trials, and consulting.
Products and services
- Laboratory Testing: Networked laboratory testing spanning a wide range of assays essential for over 65% of clinical decision-making, generating accurate data to inform diagnosis and treatment decisions
- Medical Diagnostic Services: Clinical-grade laboratory diagnostics for human and veterinary medicine enabling early detection, accurate diagnosis, treatment monitoring, and post-treatment follow-up to support patient care
- Specialty Testing Services: Multi-country specialized testing services supported by over 2,000 medical experts across more than 30 countries, ensuring expert-led testing programs for diverse patient and clinical needs
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Synlab
AmniSure
HQ: United States
Website
- Description: Provider of the AmniSure ROM Test, a one-step, minimally invasive diagnostic strip that uses proprietary technology to detect tiny quantities of amniotic fluid in vaginal discharge. FDA-cleared for marketing, reimbursable under most U.S. state Medicaid plans, and approved in other markets; AmniSure International manufactures, markets, and distributes the test worldwide.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full AmniSure company profile →
IBA Lifesciences
HQ: Germany
Website
- Description: Provider of life science technologies including the Strep-tag system for high-purity, high-yield recombinant protein purification and analysis; Strep-Tactin XT for strong, reversible binding to Twin-Strep-tag peptides; MagStrep Strep-Tactin XT beads and Strep-Tactin XT 4Flow resins for efficient purification; the MEXi mammalian cell production system; and StrepMAB-Immo for SPR analysis.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full IBA Lifesciences company profile →
Good Start Genetics
HQ: United States
Website
- Description: Provider of molecular genetic information for reproductive medicine, delivering clinically relevant and actionable insights on inherited genetic disorders to physicians and patients, enabled by a proprietary next-generation sequencing technology platform.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Good Start Genetics company profile →
Axenis
HQ: France
Website
- Description: Provider of humanized mouse models as preclinical tools in immunology for the pharmaceutical industry, biotechnology companies, and academic research, using new immunocompromised mouse strains permissive to human tissue xenograft transplantation.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Axenis company profile →
Immuneering
HQ: United States
Website
- Description: Provider of bioinformatics-driven drug discovery developing investigational medicines, including IMM-1-104 targeting RAS-mutant advanced solid tumors with once-daily oral dosing, and IMM-6-415, a Deep Cyclic Inhibitor for RAF or RAS-mutant advanced solid tumors with twice-daily dosing; also maintains an Expanded Access Policy (not currently available).
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Immuneering company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Synlab
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Synlab
2.2 - Growth funds investing in similar companies to Synlab
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Synlab
4.2 - Public trading comparable groups for Synlab
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →